Literature DB >> 4847442

Cervicovaginal fistula: an apparent increased incidence with prostaglandin F2alpha.

R Lowensohn, C Ballard.   

Abstract

Entities:  

Keywords:  Abortifacient Agents; Abortion, Drug Induced; Abortion, Induced; Acceptor Characteristics; Acceptors; Age Factors; Biology; Cervical Laceration; Clinical Research; Demographic Factors; Diseases; Endocrine System; Ethnic Groups; Family Planning; Family Planning Programs; Fertility; Fertility Control, Postconception; Fertility Measurements; Hormones; Incidence; Measurement; Oxytocin; Parity; Physiology; Pituitary Hormones; Population; Population Characteristics; Population Dynamics; Pregnancy; Pregnancy, Second Trimester; Primiparity; Prostaglandins--side effects; Reproduction; Research Methodology; Saline Solution, Hypertonic

Mesh:

Substances:

Year:  1974        PMID: 4847442     DOI: 10.1016/0002-9378(74)90258-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  5 in total

1.  Transverse posterior cervicoisthmic rupture after gemeprost pessaries for termination.

Authors:  S J Vine; A Prys-Davies; J F Pearson
Journal:  BMJ       Date:  1992-11-28

2.  Uterine rupture after intra-amniotic injection of prostaglandin E2.

Authors:  S Emery; G J Jarvis; D A Johnson
Journal:  Br Med J       Date:  1979-07-07

3.  Rupture of the cervix during prostaglandin termination of pregnancy.

Authors:  E K El-Etriby; E Daw
Journal:  Postgrad Med J       Date:  1981-04       Impact factor: 2.401

4.  Uterine rupture associated with the use of vaginal prostaglandin E2 suppositories.

Authors:  F Keller; T H Joyce
Journal:  Can Anaesth Soc J       Date:  1984-01

5.  Spontaneous delivery through a cervical tear without cervical os dilatation.

Authors:  Dusan Djokovic; Cristina Costa; Ana Martins; Shadi Abushad
Journal:  Clin Case Rep       Date:  2014-12-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.